Dr. Mattias Bernow is an MD and the CEO of Cellcolabs, a Swedish biotech company focused on the large-scale production of high-quality stem cells.
He holds a medical degree from Karolinska Institute and an MSc in Economics from the Stockholm School of Economics.
Dr. Bernow has practiced as a physician at Karolinska Hospital and worked as a management consultant at BCG.
Before leading Cellcolabs, he co-founded Doctrin, a platform that helps healthcare providers digitalize the patient journey for a more integrated healthcare system.
With a background in operations and strategy, Petter spent nine years at McKinsey & Company followed by senior management roles including CIO at AcadeMedia, CEO of Hermods AB, and Managing Director of Avonova Sweden AB.
He holds an MSc in Industrial Management from the Royal Institute of Technology in Stockholm and has studied cell biology at HEC Lausanne.
At Cellcolabs, he is driven by the mission to make stem cell treatments accessible to everyone — scaling operations to bring MSC-based therapies from an exclusive niche to a global standard in regenerative medicine.
With over 20 years of international experience, Karl has led commercial teams and brand transformations across Europe, the Middle East, Asia, Africa, and Latin America.
His career spans leadership roles in sales, marketing, and business development, where he has guided organizations through growth, new market entry, and innovation in consumer products and services.
As Commercial Director Clinical, Karl brings his global leadership experience and commercial expertise to help shape how stem cell-based treatments and clinical offerings reach patients around the world.
With a background bridging science and business, Micheal holds an MSc in Physics with a specialization in Biophysics and a BSc in Business and Economics.
Before joining Cellcolabs, he worked as a management consultant at EY. Drawn to the transformative potential of biotechnology, he is motivated by Cellcolabs’ mission to advance the field of cell therapy and make scientific innovation accessible to patients worldwide.
Emma brings broad international experience in finance and leadership, having guided organizations through growth, transformation, and rapid expansion.
Before joining Cellcolabs, she served as Director of Control at Northvolt, where she played a key role in building one of Europe’s most forward-looking industrial companies.
With a background as Group CFO across several organizations, Emma brings clarity and direction to complex operations. At Cellcolabs, she ensures the financial strength and structure needed to realize the company’s mission to democratize access to high-quality stem cells through industrial-scale production.
.webp)
With more than 30 years of experience across academia, healthcare, and biotechnology, Jan has worked at the forefront of developing and producing Advanced Therapy Medicinal Products (ATMPs).
His career includes leading roles in research, manufacturing, and regulatory affairs, where he has built pharmaceutical quality systems, established cell therapy facilities, and advanced novel treatments from lab to clinic.
At Cellcolabs, he ensures that every aspect of production meets the highest international standards of quality and compliance, supporting the company’s mission to democratize access to high-quality stem cells through industrial-scale production.
With nearly two decades of experience in cell cultivation and biologics manufacturing, Lina has held positions at AstraZeneca and Octapharma, most recently as Section Head in production, overseeing large-scale recombinant protein manufacturing.
She holds an MSc in Chemical Engineering from KTH in Stockholm.
At Cellcolabs, she brings her extensive industrial expertise to help pioneer the stem cell field and build a purpose-driven organization from the ground up.
.jpg)
With more than 25 years of experience in clinical research, Ola has led organizations and teams across project management, business development, and general management within international CROs.
He has overseen complex clinical studies from design to completion, with a focus on patient recruitment, quality, and operational excellence.
As Head of clinical success, Ola leads Clinical Success team with a focus on precision and reliability, ensuring that every clinical trial meets the highest standards of safety and scientific integrity.
Maria Rankka is an entrepreneur, health-tech investor, and board professional. She is the Chair of BICO and serves on the boards of Creades, Genova Property, Medoma, Sveab, and To Trust. Maria is also a member of the Royal Swedish Academy of Engineering Sciences (IVA).
She was one of the co-founders of ABC Labs, which became Sweden’s largest COVID-19 diagnostics laboratory during the pandemic. Previously, Maria was a partner at the global advisory firm Brunswick. Between 2010 and 2018, she was the Chief Executive Officer of the Stockholm Chamber of Commerce (SCC). She has also served as CEO of the think tank Timbro, and as a partner at Prime PR, as well as working for Carl Bildt, Sweden’s former Prime Minister.
Maria continues to support both for-profit and nonprofit organizations as an angel investor and board member, with a focus on innovation, health tech, and societal development.
Erik is the CEO of Norrsken Foundation - helping entrepreneurs solve the world's greatest challenges. Norrsken owns a VC fund backed by unicorn founders. Through multiple global start-up investments, Erik has the know-how for creating impact unicorns - making the world better for a billion people.
Erik is a board member of ABC Labs, providing large-scale automated disease testing; SNS, Center for Business and Policy Studies; and 29k, a non-profit making psychological tools available.
Previously, Erik was VP Communications and CMO at Klarna.
Simon is currently Senior Industry Expert at the international investment firm Triton Partners. He has extensive experience from private equity as Nordic Regional Advisor to Advent International and as Senior Investment Executive at Apax Partners.
During his tenures, Advent International invested in KMD, Nets and Faerch Plast and Apax Partners in Mölnlycke Healthcare, TDC, King.com, Plantasjen, Capio and Unilabs/Capio Diagnostics. In addition, Simon led the management buy-in of Humana and restructuring of Avesina and Ownit as a private Investor and advised Polaris and Acathia on their acquisition of Danica Sweden.
Simon has served on the boards of Capio, Unilabs, Humana, Avesina and Ownit among other companies.
Jonas Båtelson is an entrepreneur and investor in biopharma and digital health tech and serves as CEO of the holding company Takura AB. He has over 15 years of experience in management consulting, including as Partner at Applied Value LLC, with extensive experience in innovation, transformation, and commercial roll-outs across healthcare and life sciences in both Europe and the United States.
In addition to his role at Cellcolabs, Jonas is an active board member in several life science companies, including Medituner AB and ImagineCare AB.
In 2022, Jonas founded CuraCell by merging research teams and their assets, forming the foundation for CuraCell’s core technology.
Born in 1977, Jonas holds an MSc in Industrial Engineering from Chalmers University of Technology and a BSc in Financial Economics from the University of Gothenburg, Sweden.
Miriam Donaldsson brings extensive global experience in life sciences and healthcare innovation. After earning her undergraduate degree in Biology and Psychology from the University of Virginia, she began her career as a bench scientist at Johns Hopkins Medical School before joining a pioneering genomics start-up during its IPO phase.
Driven by a passion for advancing technology and innovation in healthcare, Miriam pursued an MBA at Harvard Business School, setting the foundation for a career focused on delivering both patient impact and shareholder value. She later joined Novartis, where she has held leadership roles for nearly two decades, contributing to strategic initiatives across global markets.
Based in Basel, Switzerland, Miriam combines her consulting and leadership work with board directorships, including at Cellcolabs AB. Outside of her professional life, she enjoys the Swiss Alps and exploring the world with her family.